Listen to our Rare Disease Day Optimum Perspecitives podcast special featuring Tahira Mathur, Patient Advocate and Kate Adcock, Director of Research &amp; Innovation at Optimum's chosen charity Muscular Dystrophy UK, alongside Jasper Morrow, consultant neurologist at University College London Hospital.&nbsp;This emotional yet hopeful episode highlights the importance of raising awareness of rare conditions, while discussing patient care, diagnosis, and genetic testing for Muscular Dystrophy.&nbsp;If you would like to contribute to the life changing work of Muscular Dystrophy UK, or find out more about Tahira's story living with GNE myopathy, visit her page here: <a href="https://www.justgiving.com/campaign/tahira" rel="noopener noreferrer" target="_blank">Tahira's Team - JustGiving</a>

Stronger together: changing the future of muscle wasting condition

Want to know how bioengineered spider silk protein fibres can be applied within the textile, biomedical and automobile industries?&nbsp;In the latest episode of Optimum Perspectives, hear from Benoit Cugnet, Head of Fiber Business Unit at AMSilk, on how this German biotech is changing the face of advanced materials.

How bioengineered spider silk-based proteins are changing the world

Want to know how to prepare yourself for the perfect IPO on NASDAQ?&nbsp;Hear from Lynn Lewis, CEO of Gilmartin Group, Optimum’s US partner, on the considerations and milestones to reach before listing.&nbsp;

How to have a perfect IPO on NASDAQ

The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.

Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers

Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.&nbsp;&nbsp;

Kling Biotherapeutics: Using  B cell tech to discover new targets and antibodies in cancer

In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.&nbsp;

DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology

Optimum’s Richard Staines talks to Feride Sahin, Senior Director of Clinical Development at Splice Bio about the importance of World Sight Day, which takes place this week.

SpliceBio: Celebrating progress in ophthalmology research on World Sight Day 

It’s time to talk about mushrooms! Or rather the deadly toxin amanitin found in the death cap mushroom, which Heidelberg Pharma is using as a cancer drug with the help of a tumour-targeting antibody, find out more in this episode featuring Heidelberg Pharma's CEO, Andreas Pahl.

Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine

Check out Optimum’s latest podcast episode profiling our client Resolution Therapeutics. Lara Campana, VP of Research Operations outlines the company’s technology based around pro-regenerative macrophages and its potential to treat liver disease.

Resolution Therapeutics: pioneering macrophage therapies for liver diseases

Interviews with industry leaders of the healthcare sector.

<a href="https://www.optimumcomms.com/podcast/" rel="noopener noreferrer" target="_blank">Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.</a>Follow us on <a href="https://www.linkedin.com/company/optimum-strategic-communications/" rel="noopener noreferrer" target="_blank">Linkedin</a> and <a href="https://twitter.com/OptimumComms" rel="noopener noreferrer" target="_blank">Twitter</a> for news and highlights on the life sciences industry. Reach out via our contact page on our website: <a href="https://www.optimumcomms.com/" rel="noopener noreferrer" target="_blank">www.optimumcomms.com</a>

Optimum Perspectives

Social Media

Follow